A portable point-of-care diagnostic system for rapid, multiplexed detection and staging of chronic kidney disease
NephroSense is a portable, low-cost device that quickly detects early-stage chronic kidney disease by analyzing blood and urine samples for key biomarkers, providing lab-quality results and CKD stage classification in under 10 minutes at the point of care.
Background
Chronic Kidney Disease (CKD) represents a substantial global health crisis, affecting hundreds of millions of people worldwide and imposing immense healthcare costs. Early detection of CKD is paramount for effective management, as timely intervention can significantly slow disease progression and potentially avert the need for highly invasive and expensive treatments such as dialysis or organ transplantation. A considerable portion of the affected population remains undiagnosed or unaware of their condition, highlighting a critical unmet need for accessible and efficient diagnostic tools.
Current diagnostic approaches for CKD predominantly rely on centralized laboratory testing, which poses several significant challenges. These traditional methods are often characterized by slow turnaround times, requiring samples to be transported and processed off-site, leading to delays in obtaining crucial results. Furthermore, existing lab-based tests can be costly and necessitate separate analyses for various biomarkers, making them financially burdensome and geographically inaccessible for a large segment of the global population, particularly in underserved areas. This cumulative effect of inaccessibility, cost, and delays frequently results in late-stage diagnoses, complicating treatment and worsening patient outcomes.
Technology
NephroSense is a portable, low-cost, point-of-care diagnostic device designed for early chronic kidney disease detection. It simultaneously analyzes four key renal biomarkers—serum creatinine, cystatin C, urine albumin, and urine creatinine—using microliter blood and small urine samples. The system employs electrochemical biosensors on functionalized screen-printed carbon electrodes and disposable microfluidic cartridges with preloaded reagents to deliver quantitative, lab-quality results in under 10 minutes. A custom-built software suite performs real-time signal processing, automatically calculates estimated glomerular filtration rate (eGFR) and albumin-to-creatinine ratio (ACR), displays CKD stage classification per KDIGO guidelines, and supports wireless data transmission.
This technology differentiates itself by integrating dual-modality detection for both blood and urine biomarkers into a single, portable system, a significant departure from traditional, expensive, and slow lab-based testing. Its use of cost-effective, multiplexed carbon screen-printed electrodes and preloaded microfluidic cartridges simplifies the process, minimizes user error, and enables rapid, lab-quality results directly at the point of care. By providing immediate, comprehensive CKD staging, the device empowers timely intervention, aiming to prevent disease progression, reduce healthcare costs, and improve access to critical diagnostics, particularly for underserved populations globally.
Benefits
- Enables rapid, point-of-care detection of chronic kidney disease with lab-quality quantitative results in under 10 minutes.
- Simultaneously analyzes multiple critical renal biomarkers from microliter-scale blood and urine samples, improving diagnostic accuracy.
- Portable and low-cost design increases accessibility, especially for underserved populations and resource-limited settings.
- Disposable microfluidic cartridges with preloaded reagents simplify testing, reduce user error, and prevent cross-contamination.
- Custom software automates data processing, CKD staging, and supports wireless transmission for seamless clinical integration.
- Reduces healthcare costs by enabling early detection and intervention, potentially preventing disease progression and costly treatments.
- Minimizes environmental impact through low reagent use and reduced need for sample transport.
- Validated high sensitivity and reproducibility ensure reliable and robust biomarker detection.
Applications
- Primary care CKD screening
- Rural and remote health clinics
- Emergency department rapid triage
- Home-based kidney monitoring
- Mobile health outreach programs
Additional info
This portable diagnostic system detects early chronic kidney disease by simultaneously analyzing four renal biomarkers from microliter blood and small urine samples. It utilizes electrochemical biosensors on functionalized screen-printed carbon electrodes within disposable microfluidic cartridges. Custom software processes signals, calculates eGFR/ACR, and displays CKD stage, providing lab-quality results rapidly.